Understanding and preventing the development of post-stroke dementia

References

• Leys D, Henon H, Mackowiak-Cordoliani MA, et al. Poststroke dementia. Lancet Neurol 2005;4:752-9
   PubMed Web of Science ®Google Scholar
• Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 2009;8:1006-18
   PubMed Web of Science ®Google Scholar
• Kalaria RN, Mukaetova-Ladinska EB. Delirium, dementia and senility. Brain 2012;135:2582-4
   PubMedGoogle Scholar
• Melkas S, Laurila JV, Vataja R, et al. Post-stroke delirium in relation to dementia and long-term mortality. Int J Geriatr Psychiatry 2012;27:401-8
   PubMed Web of Science ®Google Scholar
• Pasi M, Poggesi A, Salvadori E, et al. Post-stroke dementia and cognitive impairment. Front Neurol Neurosci 2012;30:65-9
   PubMedGoogle Scholar
• Bejot Y, Jacquin A, Rouaud O, et al. One-year survival of demented stroke patients: data from the Dijon Stroke Registry, France (1985-2008). Eur J Neurol 2012;19:712-17
   PubMedGoogle Scholar
• Altieri M, Di Piero V, Pasquini M, et al. Delayed poststroke dementia: a 4-year follow-up study. Neurology 2004;62:2193-7
   PubMed Web of Science ®Google Scholar
• Allan LM, Rowan EN, Firbank MJ, et al. Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors. Brain 2012;134:3716-27
   Google Scholar
• Hachinski V, Iadecola C, Petersen RC, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006;37:2220-41
   PubMed Web of Science ®Google Scholar
• Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:2672-713
   PubMed Web of Science ®Google Scholar
• Sachdev P, Kalaria R, O’Brien J, et al. Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement. Alzheimer Dis Assoc Disord 2014. [Epub ahead of print]
   PubMedGoogle Scholar
• de Koning I, van Kooten F, Koudstaal PJ, et al. Diagnostic value of the Rotterdam-CAMCOG in post-stroke dementia. J Neurol Neurosurg Psychiatry 2005;76:263-5
   PubMed Web of Science ®Google Scholar
• Pendlebury ST, Cuthbertson FC, Welch SJ, et al. Underestimation of cognitive impairment by mini-mental state examination versus the Montreal cognitive assessment in patients with transient ischemic attack and stroke: a population-based study. Stroke 2010;41:1290-3
   PubMed Web of Science ®Google Scholar
• Dong Y, Sharma VK, Chan BP, et al. The Montreal Cognitive Assessment (MoCA) is superior to the Mini-Mental State Examination (MMSE) for the detection of vascular cognitive impairment after acute stroke. J Neurol Sci 2010;299:15-18
   PubMed Web of Science ®Google Scholar
• Salvadori E, Pasi M, Poggesi A, et al. Predictive value of MoCA in the acute phase of stroke on the diagnosis of mid-term cognitive impairment. J Neurol 2013;260:2220-7
   PubMed Web of Science ®Google Scholar
• Kalaria RN, Kenny RA, Ballard CG, et al. Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci 2004;226:75-80
   PubMed Web of Science ®Google Scholar
• Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-60
   PubMed Web of Science ®Google Scholar
• Jacova C, Pearce LA, Costello R, et al. Cognitive impairment in lacunar strokes: the SPS3 trial. Ann Neurol 2012;72:351-62
   PubMed Web of Science ®Google Scholar
• Kase CS, Wolf PA, Kelly-Hayes M, et al. Intellectual decline after stroke: the Framingham Study. Stroke 1998;29:805-12
   PubMed Web of Science ®Google Scholar
• Prencipe M, Ferretti C, Casini AR, et al. Stroke, disability, and dementia: results of a population survey. Stroke 1997;28:531-6
   PubMed Web of Science ®Google Scholar
• Ballard C, Rowan E, Stephens S, et al. Prospective follow-up study between 3 and 15 months after stroke: improvements and decline in cognitive function among dementia-free stroke survivors >75 years of age. Stroke 2003;34:2440-4
   PubMed Web of Science ®Google Scholar
• Gemmell E, Bosomworth H, Allan L, et al. Hippocampal neuronal atrophy and cognitive function in delayed poststroke and aging-related dementias. Stroke 2012;43:808-14
   PubMedGoogle Scholar
• Barba R, Martinez-Espinosa S, Rodriguez-Garcia E, et al. Poststroke dementia : clinical features and risk factors. Stroke 2000;31:1494-501
   PubMed Web of Science ®Google Scholar
• Pohjasvaara T, Erkinjuntti T, Ylikoski R, et al. Clinical determinants of poststroke dementia. Stroke 1998;29:75-81
   PubMed Web of Science ®Google Scholar
• Tatemichi TK, Desmond DW, Mayeux R, et al. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 1992;42:1185-93
   PubMed Web of Science ®Google Scholar
• Pendlebury ST, Rothwell PM. Risk of recurrent stroke, other vascular events and dementia after transient ischaemic attack and stroke. Cerebrovasc Dis 2009;27(Suppl 3):1-11
   PubMedGoogle Scholar
• Chaudhari TS, Verma R, Garg RK, et al. Clinico-radiological predictors of vascular cognitive impairment (VCI) in patients with stroke: a prospective observational study. J Neurol Sci 2014;340:150-8
   PubMedGoogle Scholar
• Jacquin A, Binquet C, Rouaud O, et al. Post-stroke cognitive impairment: high prevalence and determining factors in a cohort of mild stroke. J Alzheimers Dis 2014;40:1029-38
   PubMed Web of Science ®Google Scholar
• Ihle-Hansen H, Thommessen B, Wyller TB, et al. Incidence and subtypes of MCI and dementia 1 year after first-ever stroke in patients without pre-existing cognitive impairment. Dement Geriatr Cogn Disord 2011;32:401-7
   PubMed Web of Science ®Google Scholar
• Brodaty H, Liu Z, Withall A, et al. The longitudinal course of post-stroke apathy over five years. J Neuropsychiatry Clin Neurosci 2013;25:283-91
   PubMedGoogle Scholar
• Park JH, Kim BJ, Bae HJ, et al. Impact of post-stroke cognitive impairment with no dementia on health-related quality of life. J Stroke 2013;15:49-56
   PubMedGoogle Scholar
• Hassan A, Markus HS. Genetics and ischaemic stroke. Brain 2000;123(Pt 9):1784-812
   PubMedGoogle Scholar
• Arpa A, del Ser T, Goda G, et al. Apolipoprotein E, angiotensin-converting enzyme and alpha-1-antichymotrypsin genotypes are not associated with post-stroke dementia. J Neurol Sci 2003;210:77-82
   PubMed Web of Science ®Google Scholar
• Klimkowicz A, Slowik A, Dziedzic T, et al. Post-stroke dementia is associated with alpha(1)-antichymotrypsin polymorphism. J Neurol Sci 2005;234:31-6
   PubMed Web of Science ®Google Scholar
• Skoog I, Hesse C, Aevarsson O, et al. A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality. J Neurol Neurosurg Psychiatry 1998;64:37-43
   PubMed Web of Science ®Google Scholar
• Slooter AJ, Tang MX, van Duijn CM, et al. Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation. JAMA 1997;277:818-21
   PubMed Web of Science ®Google Scholar
• Ballard CG, Morris CM, Rao H, et al. APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment. Neurology 2004;63:1399-402
   PubMedGoogle Scholar
• Song J, Lee WT, Park KA, et al. Association between risk factors for vascular dementia and adiponectin. Biomed Res Int 2014;2014:261672
   PubMed Web of Science ®Google Scholar
• Moroney JT, Bagiella E, Desmond DW, et al. Risk factors for incident dementia after stroke. Role of hypoxic and ischemic disorders. Stroke 1996;27:1283-9
   PubMedGoogle Scholar
• Pohjasvaara T, Mantyla R, Salonen O, et al. How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia. Arch Neurol 2000;57:1295-300
   PubMedGoogle Scholar
• Vataja R, Pohjasvaara T, Mantyla R, et al. MRI correlates of executive dysfunction in patients with ischaemic stroke. Eur J Neurol 2003;10:625-31
   PubMed Web of Science ®Google Scholar
• Melkas S, Vataja R, Oksala NK, et al. Depression-executive dysfunction syndrome relates to poor poststroke survival. Am J Geriatr Psychiatry 2010;18:1007-16
   PubMed Web of Science ®Google Scholar
• Allan LM, Rowan EN, Thomas AJ, et al. Long-term incidence of depression and predictors of depressive symptoms in older stroke survivors. Br J Psychiatry 2013;203:453-60
   PubMed Web of Science ®Google Scholar
• Rowan E, Morris CM, Stephens S, et al. Impact of hypertension and apolipoprotein E4 on poststroke cognition in subjects >75 years of age. Stroke 2005;36:1864-8
   PubMedGoogle Scholar
• Yang J, Wong A, Wang Z, et al. Risk factors for incident dementia after stroke and transient ischemic attack. Alzheimers Dement 2014. [ Epub ahead of print]
   Google Scholar
• Savva GM, Stephan BC. Epidemiological studies of the effect of stroke on incident dementia: a systematic review. Stroke 2010;41:e41-6
   PubMed Web of Science ®Google Scholar
• Panza F, Solfrizzi V, Logroscino G, et al. Current epidemiological approaches to the metabolic-cognitive syndrome. J Alzheimers Dis 2012;30(Suppl 2):S31-75
   PubMedGoogle Scholar
• Bejot Y, Aboa-Eboule C, Durier J, et al. Prevalence of early dementia after first-ever stroke: a 24-year population-based study. Stroke 2011;42:607-12
   PubMed Web of Science ®Google Scholar
• Censori B, Manara O, Agostinis C, et al. Dementia after first stroke. Stroke 1996;27:1205-10
   PubMed Web of Science ®Google Scholar
• Inzitari D, Di Carlo A, Pracucci G, et al. Incidence and determinants of poststroke dementia as defined by an informant interview method in a hospital-based stroke registry. Stroke 1998;29:2087-93
   PubMed Web of Science ®Google Scholar
• Reitz C, Bos MJ, Hofman A, et al. Prestroke cognitive performance, incident stroke, and risk of dementia: the Rotterdam Study. Stroke 2008;39:36-41
   PubMed Web of Science ®Google Scholar
• Gamaldo A, Moghekar A, Kilada S, et al. Effect of a clinical stroke on the risk of dementia in a prospective cohort. Neurology 2006;67:1363-9
   PubMed Web of Science ®Google Scholar
• McColl BW, Allan SM, Rothwell NJ. Systemic inflammation and stroke: aetiology, pathology and targets for therapy. Biochem Soc Trans 2007;35:1163-5
   PubMed Web of Science ®Google Scholar
• Meisel C, Meisel A. Suppressing immunosuppression after stroke. N Engl J Med 2011;365:2134-6
   PubMed Web of Science ®Google Scholar
• Gold AB, Herrmann N, Swardfager W, et al. The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment. J Neuroinflammation 2011;8:17
   PubMedGoogle Scholar
• Swardfager W, Winer DA, Herrmann N, et al. Interleukin-17 in post-stroke neurodegeneration. Neurosci Biobehav Rev 2013;37:436-47
   PubMedGoogle Scholar
• Stephens S, Kenny RA, Rowan E, et al. Neuropsychological characteristics of mild vascular cognitive impairment and dementia after stroke. Int J Geriatr Psychiatry 2004;19:1053-7
   PubMed Web of Science ®Google Scholar
• Onyike CU. Cerebrovascular disease and dementia. Int Rev Psychiatry 2006;18:423-31
   PubMed Web of Science ®Google Scholar
• Schnider A, Regard M, Landis T. Anterograde and retrograde amnesia following bitemporal infarction. Behav Neurol 1994;7:87-92
   PubMedGoogle Scholar
• Pantoni L, Basile AM, Romanelli M, et al. Abulia and cognitive impairment in two patients with capsular genu infarct. Acta Neurol Scand 2001;104:185-90
   PubMedGoogle Scholar
• Sachdev PS, Chen X, Joscelyne A, et al. Hippocampal size and dementia in stroke patients: the Sydney stroke study. J Neurol Sci 2007;260:71-7
   PubMed Web of Science ®Google Scholar
• Burton EJ, Kenny RA, O’Brien J, et al. White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients. Stroke 2004;35:1270-5
   PubMed Web of Science ®Google Scholar
• Firbank MJ, Burton EJ, Barber R, et al. Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivors. Neurobiol Aging 2007;28:1664-9
   PubMed Web of Science ®Google Scholar
• Akiguchi I, Tomimoto H, Wakita H, et al. Topographical and cytopathological lesion analysis of the white matter in Binswanger’s disease brains. Acta Neuropathol 2004;107:563-70
   PubMedGoogle Scholar
• Ihara M, Tomimoto H, Ishizu K, et al. Decrease in cortical benzodiazepine receptors in symptomatic patients with leukoaraiosis: a positron emission tomography study. Stroke 2004;35:942-7
   PubMed Web of Science ®Google Scholar
• Kandiah N, Wiryasaputra L, Narasimhalu K, et al. Frontal subcortical ischemia is crucial for post stroke cognitive impairment. J Neurol Sci 2011;309:92-5
   PubMedGoogle Scholar
• Fernando MS, Simpson JE, Matthews F, et al. White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke 2006;37:1391-8
   PubMed Web of Science ®Google Scholar
• Polvikoski TM, van Straaten EC, Barkhof F, et al. Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old. Neurology 2010;75:2071-8
   PubMedGoogle Scholar
• Ihara M, Polvikoski TM, Hall R, et al. Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer’s disease, and dementia with Lewy bodies. Acta Neuropathol 2010;119:579-89
   PubMed Web of Science ®Google Scholar
• Jokinen H, Schmidt R, Ropele S, et al. Diffusion changes predict cognitive and functional outcome: the LADIS study. Ann Neurol 2013;73:576-83
   PubMedGoogle Scholar
• Boon A, Lodder J, Heuts-van Raak L, et al. Silent brain infarcts in 755 consecutive patients with a first-ever supratentorial ischemic stroke. Relationship with index-stroke subtype, vascular risk factors, and mortality. Stroke 1994;25:2384-90
   PubMed Web of Science ®Google Scholar
• Mok VC, Wong A, Lam WW, et al. Cognitive impairment and functional outcome after stroke associated with small vessel disease. J Neurol Neurosurg Psychiatry 2004;75:560-6
   PubMed Web of Science ®Google Scholar
• Corea F, Henon H, Pasquier F, et al. Silent infarcts in stroke patients: patient characteristics and effect on 2-year outcome. J Neurol 2001;248:271-8
   PubMed Web of Science ®Google Scholar
• Smith EE, Schneider JA, Wardlaw JM, et al. Cerebral microinfarcts: the invisible lesions. Lancet Neurol 2012;11:272-82
   PubMedGoogle Scholar
• Okamoto Y, Ihara M, Fujita Y, et al. Cortical microinfarcts in Alzheimer’s disease and subcortical vascular dementia. Neuroreport 2009;20:990-6
   PubMedGoogle Scholar
• Kovari E, Gold G, Herrmann FR, et al. Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke 2004;35:410-14
   PubMed Web of Science ®Google Scholar
• Van der Flier WM, Cordonnier C. Microbleeds in vascular dementia: clinical aspects. Exp Gerontol 2012;47:853-7
   PubMedGoogle Scholar
• Cordonnier C, van der Flier WM, Sluimer JD, et al. Prevalence and severity of microbleeds in a memory clinic setting. Neurology 2006;66:1356-60
   PubMed Web of Science ®Google Scholar
• Haglund M, Passant U, Sjobeck M, et al. Cerebral amyloid angiopathy and cortical microinfarcts as putative substrates of vascular dementia. Int J Geriatr Psychiatry 2006;21:681-7
   PubMedGoogle Scholar
• Suter OC, Sunthorn T, Kraftsik R, et al. Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke 2002;33:1986-92
   PubMed Web of Science ®Google Scholar
• Firbank MJ, Allan LM, Burton EJ, et al. Neuroimaging predictors of death and dementia in a cohort of older stroke survivors. J Neurol Neurosurg Psychiatry 2012;83:263-7
   PubMed Web of Science ®Google Scholar
• Firbank MJ, He J, Blamire AM, et al. Cerebral blood flow by arterial spin labeling in poststroke dementia. Neurology 2011;76:1478-84
   PubMedGoogle Scholar
• Kim BJ, Oh MY, Jang MS, et al. Medial temporal atrophy and memory dysfunction in poststroke cognitive impairment-no dementia. J Clin Neurol 2012;8:43-50
   PubMedGoogle Scholar
• Snaphaan L, Rijpkema M, van Uden I, et al. Reduced medial temporal lobe functionality in stroke patients: a functional magnetic resonance imaging study. Brain 2009;132:1882-8
   Google Scholar
• de Leeuw FE, Barkhof F, Scheltens P. White matter lesions and hippocampal atrophy in Alzheimer’s disease. Neurology 2004;62:310-12
   PubMedGoogle Scholar
• Nishio K, Ihara M, Yamasaki N, et al. A mouse model characterizing features of vascular dementia with hippocampal atrophy. Stroke 2010;41:1278-84
   PubMedGoogle Scholar
• Henon H, Durieu I, Guerouaou D, et al. Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology 2001;57:1216-22
   PubMed Web of Science ®Google Scholar
• Pantoni L, Sarti C, Alafuzoff I, et al. Postmortem examination of vascular lesions in cognitive impairment: a survey among neuropathological services. Stroke 2006;37:1005-9
   PubMed Web of Science ®Google Scholar
• Yoon CW, Shin JS, Kim HJ, et al. Cognitive deficits of pure subcortical vascular dementia vs. Alzheimer disease: piB-PET-based study. Neurology 2013;80:569-73
   PubMedGoogle Scholar
• Maruyama M, Shimada H, Suhara T, et al. Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron 2013;79:1094-108
   PubMed Web of Science ®Google Scholar
• Teuschl Y, Matz K, Brainin M. Prevention of post-stroke cognitive decline: a review focusing on lifestyle interventions. Eur J Neurol 2013;20:35-49
   PubMed Web of Science ®Google Scholar
• Douiri A, McKevitt C, Emmett ES, et al. Long-term effects of secondary prevention on cognitive function in stroke patients. Circulation 2013;128:1341-8
   PubMed Web of Science ®Google Scholar
• Kokmen E, Whisnant JP, O’Fallon WM, et al. Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984). Neurology 1996;46:154-9
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Giles MF, Chandratheva A, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 2007;370:1432-42
   PubMed Web of Science ®Google Scholar
• Tzourio C, Anderson C, Chapman N, et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003;163:1069-75
   PubMed Web of Science ®Google Scholar
• Forette F, Seux ML, Staessen JA, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998;352:1347-51
   PubMed Web of Science ®Google Scholar
• Diener HC, Sacco RL, Yusuf S, et al. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol 2008;7:875-84
   PubMed Web of Science ®Google Scholar
• Benavente OR, Pearce LA, Bazan C, et al. Clinical-MRI correlations in a multiethnic cohort with recent lacunar stroke: the SPS3 trial. Int J Stroke 2014. [ Epub ahead of print]
   Google Scholar
• Pasquier F, Boulogne A, Leys D, et al. Diabetes mellitus and dementia. Diabetes Metab 2006;32:403-14
   PubMed Web of Science ®Google Scholar
• Crane PK, Walker R, Hubbard RA, et al. Glucose levels and risk of dementia. N Engl J Med 2013;369:540-8
   PubMed Web of Science ®Google Scholar
• Action to Control Cardiovascular Risk in Diabetes Study G. Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59
   PubMed Web of Science ®Google Scholar
• Meyer JS, Rogers RL, McClintic K, et al. Randomized clinical trial of daily aspirin therapy in multi-infarct dementia. A pilot study. J Am Geriatr Soc 1989;37:549-55
   PubMed Web of Science ®Google Scholar
• Perry EK, Perry RH, Blessed G, et al. Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathol Appl Neurobiol 1978;4:273-7
   PubMed Web of Science ®Google Scholar
• O’Brien JT, Burns A; BAP Dementia Consensus Group. Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology. J Psychopharmacol 2011;25:997-1019
   PubMed Web of Science ®Google Scholar
• Erkinjuntti T, Kurz A, Gauthier S, et al. Efficacy of galantamine in probable vascular dementia and Alzheimer’s disease combined with cerebrovascular disease: a randomised trial. Lancet 2002;359:1283-90
   PubMed Web of Science ®Google Scholar
• Dichgans M, Markus HS, Salloway S, et al. Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL. Lancet Neurol 2008;7:310-18
   PubMed Web of Science ®Google Scholar
• Kavirajan H, Schneider LS. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials. Lancet Neurol 2007;6:782-92
   PubMed Web of Science ®Google Scholar
• Perry E, Ziabreva I, Perry R, et al. Absence of cholinergic deficits in "pure" vascular dementia. Neurology 2005;64:132-3
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Shioda N, Han F, et al. Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation. Brain Res 2009;1295:218-29
   PubMed Web of Science ®Google Scholar
• Lai TW, Zhang S, Wang YT. Excitotoxicity and stroke: identifying novel targets for neuroprotection. Prog Neurobiol 2014;115:157-88
   PubMed Web of Science ®Google Scholar
• Dawson VL, Hsu CY, Liu TH, et al. Receptor alterations in subcortical structures after bilateral middle cerebral artery infarction of the cerebral cortex. Exp Neurol 1994;128:88-96
   PubMedGoogle Scholar
• Areosa Sastre A, McShane R, Sherriff F. Memantine for dementia. Cochrane Database Syst Rev 2004(4):CD003154
   Google Scholar
• Demaerschalk BM, Wingerchuk DM. Treatment of vascular dementia and vascular cognitive impairment. Neurologist 2007;13:37-41
   PubMed Web of Science ®Google Scholar
• Wilcock G, Mobius HJ, Stoffler A, et al. A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). Int Clin Psychopharmacol 2002;17:297-305
   PubMed Web of Science ®Google Scholar
• Orgogozo JM, Rigaud AS, Stoffler A, et al. Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300). Stroke 2002;33:1834-9
   PubMed Web of Science ®Google Scholar
• Clark WM, Clark TD. Stroke: treatment for acute stroke – the end of the citicoline saga. Nat Rev Neurol 2012;8:484-5
   PubMedGoogle Scholar
• Adibhatla RM. Citicoline in stroke and TBI clinical trials. Nat Rev Neurol 2013;9:173
   PubMedGoogle Scholar
• Alvarez-Sabin J, Ortega G, Jacas C, et al. Long-term treatment with citicoline may improve poststroke vascular cognitive impairment. Cerebrovasc Dis 2013;35:146-54
   PubMed Web of Science ®Google Scholar
• Gorelick PB. Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials. Ann N Y Acad Sci 2010;1207:155-62
   PubMed Web of Science ®Google Scholar
• Wong CH, Jenne CN, Lee WY, et al. Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science 2011;334:101-5
   PubMed Web of Science ®Google Scholar
• Maki T, Ihara M, Fujita Y, et al. Angiogenic and vasoprotective effects of adrenomedullin on prevention of cognitive decline after chronic cerebral hypoperfusion in mice. Stroke 2011;42:1122-8
   PubMed Web of Science ®Google Scholar
• Fujita Y, Ihara M, Ushiki T, et al. Early protective effect of bone marrow mononuclear cells against ischemic white matter damage through augmentation of cerebral blood flow. Stroke 2010;41:2938-43
   PubMed Web of Science ®Google Scholar
• Rosado-de-Castro PH, Pimentel-Coelho PM, da Fonseca LM, et al. The rise of cell therapy trials for stroke: review of published and registered studies. Stem Cells Dev 2013;22:2095-111
   PubMedGoogle Scholar
• Honmou O, Houkin K, Matsunaga T, et al. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 2011;134:1790-807
   PubMed Web of Science ®Google Scholar
• Guekht A, Skoog I, Korczyn AD, et al. A randomised, double-blind, placebo-controlled trial of actovegin in patients with post-stroke cognitive impairment: ARTEMIDA study design. Dement Geriatr Cogn Dis Extra 2013;3:459-67
   PubMedGoogle Scholar
• Jacquin A, Aboa-Eboule C, Rouaud O, et al. Prior transient ischemic attack and dementia after subsequent ischemic stroke. Alzheimer Dis Assoc Disord 2012;26:307-13
   PubMedGoogle Scholar
• Lin JH, Lin RT, Tai CT, et al. Prediction of poststroke dementia. Neurology 2003;61:343-8
   PubMed Web of Science ®Google Scholar
• Gregoire SM, Smith K, Jager HR, et al. Cerebral microbleeds and long-term cognitive outcome: longitudinal cohort study of stroke clinic patients. Cerebrovasc Dis 2012;33:430-5
   PubMed Web of Science ®Google Scholar